The Insights Association has scored several policy victories in recent months – on Capitol Hill and in states across the U.S. Here are some of the highlights with content links for you and your team, all made possible by your membership.
A look back, counting down the Insights Association's top seven advocacy wins from the last decade that helped our marketing research and data analytics industry members create competitive advantage.
A (data) gathering storm? An update on legislation and regulation impacting the insights industry in 2019
Insights Association lobbyist Howard Fienberg provides a 2019 update on legislation and regulation impacting the marketing research and data analytics industry for Quirks magazine.
Each time the state of Minnesota has tried to clarify treatment of respondent incentives for the participation of health care practitioners in marketing research sponsored by pharmaceutical manufacturers, companies still end up confused. What do the law, regulations and guidance tell us?
Philadelphia Rejects Bill That Would Have Banned Pharmaceutical Marketing Research with Healthcare Professionals
Legislation in the city of Philadelphia that would have cut off pharmaceutical marketing research with doctors was defeated in the city council yesterday.
The Insights Association contributes to Pharma Market Research Report 14th Annual Predictions Issue
New regulations in New Jersey restricting interactions between medical professionals and pharmaceutical manufacturers should not impede marketing research, thanks to the advocacy of the Insights As
MM&M magazine interviews the Insights Association while examining the growing regulation of pharmaceutical marketing research
The Insights Association testified in New Jersey about proposed regulations on payments to medical professionals, urging an exemption for pharmaceutical marketing research incentive payments.
As the state legislature considers a bill to prohibit most payments from the pharmaceutical industry to health care providers in connection with their participation in research, a new survey indicates the public health benefits of pharmaceutical marketing research studies of doctors.